查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1644217

全球強度調控放射治療市場

Intensity Modulated Radiation Therapy
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 160 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球強度調控放射治療市場規模將達到 35 億美元

2024 年全球強度調控放射治療估計為 26 億美元，預計到 2030 年將達到 35 億美元，2024-2030 年分析期間的複合年成長率為 4.7%。電子束治療是該報告分析的領域之一，預計其複合年成長率為 4.7%，到分析期結束時將達到 13 億美元。預計在分析期內，碳離子放射線治療領域的複合年成長率為 4.0%。

美國市場規模估計為 6.911 億美元，中國市場預計年均成長率為 4.7%

預計 2024 年美國強度調控放射治療市場價值將達 6.911 億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 5.597 億美元，2024-2030 年分析期間的複合年成長率為 4.7%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 4.4% 和 4.2%。在歐洲，德國的複合年成長率預計為 4.0%。

全球強度調控放射治療市場-主要趨勢與促進因素摘要

為什麼強度調控放射治療會改變癌症治療？

強度調控放射治療(IMRT) 在瞄準腫瘤方面具有無與倫比的精確度，同時最大限度地減少了對周圍健康組織的損害，並已成為晚期癌症治療的基石。這項創新技術透過調節輻射束的強度，能夠提供高度適形的輻射劑量，使其在治療複雜和形狀不規則的腫瘤方面特別有效。隨著全球癌症發生率持續上升，與傳統放射療法相比，IMRT 可以改善治療效果並減少副作用，因此正成為腫瘤內科醫師的首選。 IMRT 對於治療位於重要器官附近的癌症特別有益，例如頭頸癌、前列腺癌和腦腫瘤。其高精度可減少併發症並保留敏感區域的功能，從而顯著改善患者的生活品質。此外，隨著越來越多的醫療保健提供者和癌症治療中心將 IMRT 納入其治療中，其應用範圍和採用範圍正在擴大。對以患者為中心的護理的日益關注以及對先進的非侵入性治療方案的需求不斷成長，推動了 IMRT 在已開發和新興醫療保健市場的廣泛應用。

科技進步如何增強 IMRT 能力？

IMRT 領域取得了重大技術進步，進一步鞏固了其作為放射腫瘤學領先治療方法的地位。影像導航放射治療(IGRT) 與 IMRT 的結合透過結合考慮腫瘤運動和患者位置的即時成像顯著提高了治療精度。這種組合可以將輻射精確地傳送到預定目標，即使是在肺部和腹部等動態解剖區域。此外，治療計劃軟體和機器學習演算法的進步使得放射治療更加個人化和適應性強。這些創新使臨床醫生能夠根據患者的個別特徵、腫瘤生物學和治療反應來制定治療方案。此外，自動化治療計劃系統的採用減少了開發複雜 IMRT通訊協定所需的時間，提高了腫瘤中心的業務效率。此外，質子治療與IMRT等新技術的結合，使得治療更加精準，為兒童及難治性癌症的治療開闢了新的前景。

IMRT 應用的主要市場趨勢是什麼？

從大型腫瘤中心到小型社區醫院，IMRT 的應用正在各種醫療保健環境中迅速擴大。在北美、歐洲等已開發地區，完善的醫療基礎設施和優惠的報銷政策促進了IMRT的廣泛應用。此外，由於生活方式相關癌症的增加和人口老化，這些地區對先進放射治療技術的需求激增。由於醫療保健投入的增加和對晚期癌症治療方案的認知不斷提高，新興市場，尤其是亞太地區，對 IMRT 的採用顯著增加。中國和印度等國家的政府優先建立配備調強放射治療（IMRT）等最尖端科技的專門癌症治療中心，以應對該地區日益嚴重的癌症負擔。此外，私人醫療保健提供者擴大與提供尖端IMRT解決方案的技術供應商合作，以提高這些地區的腫瘤治療品質。

哪些因素將推動IMRT市場的成長？

IMRT市場的成長受到多種因素的推動，包括全球癌症發生率的增加、精準醫療的需求不斷成長以及放射治療技術的進步。提高對IMRT在減少治療相關併發症和提高存活率方面益處的認知是市場成長的主要動力。此外，旨在改善晚期癌症治療機會的政府支持政策和資助措施在擴大市場方面發揮重要作用。最終用途趨勢也影響市場，醫院、癌症治療中心和專科放射腫瘤診所是 IMRT 的主要使用者。人們對門診癌症治療的偏好日益成長，進一步推動了對緊湊、經濟高效的 IMRT 系統的需求。同時，遠端醫療和遠端醫療計畫的進步使得IMRT在醫療資源匱乏的地區更加廣泛地普及，解決了癌症治療的地理差異問題。綜合起來，這些因素強調了 IMRT 在徹底改變癌症治療以及滿足全球患者和醫療保健提供者不斷變化的需求方面的戰略重要性。

部分

輻射類型（電子輻射、碳離子輻射、光子輻射、質子輻射）、應用（乳腺癌應用、前列腺癌應用、婦科癌症應用、肺癌應用、腦腫瘤應用、其他應用）

受訪公司範例（52家值得關注的公司）

  • Accuray, Inc.
  • Brainlab AG
  • Elekta AB
  • IBA Dosimetry GmbH
  • Mevion Medical Systems, Inc.
  • Panacea Medical Technologies Pvt. Ltd.
  • Protom International
  • RAYSEARCH Laboratories AB
  • Reflexion Medical, Inc.
  • Siemens Healthineers AG

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP31654

Global Intensity Modulated Radiation Therapy Market to Reach US$3.5 Billion by 2030

The global market for Intensity Modulated Radiation Therapy estimated at US$2.6 Billion in the year 2024, is expected to reach US$3.5 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Electron Radiation Therapy, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Carbon-Ion Radiation Therapy segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$691.1 Million While China is Forecast to Grow at 4.7% CAGR

The Intensity Modulated Radiation Therapy market in the U.S. is estimated at US$691.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$559.7 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.4% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Intensity Modulated Radiation Therapy Market - Key Trends & Drivers Summarized

Why Is Intensity Modulated Radiation Therapy Transforming Cancer Treatment?

Intensity Modulated Radiation Therapy (IMRT) has emerged as a cornerstone in advanced cancer treatment, offering unparalleled precision in targeting tumors while minimizing damage to surrounding healthy tissues. This innovative technology allows for the delivery of highly conformal radiation doses by modulating the intensity of radiation beams, making it particularly effective in treating complex and irregularly shaped tumors. As cancer prevalence continues to rise globally, IMRT is becoming a preferred choice for oncologists due to its ability to improve treatment outcomes and reduce side effects compared to traditional radiation therapies. IMRT is especially beneficial in treating cancers located near critical organs, such as head and neck cancers, prostate cancer, and brain tumors. Its precision has significantly enhanced the quality of life for patients by reducing complications and preserving functionality in sensitive areas. Furthermore, as more healthcare providers and cancer treatment centers integrate IMRT into their offerings, its accessibility and adoption have expanded. The growing focus on patient-centric care and the increasing demand for advanced, non-invasive treatment options are driving the widespread adoption of IMRT across developed and emerging healthcare markets.

How Are Technological Advancements Enhancing IMRT’s Capabilities?

The field of IMRT has witnessed remarkable technological advancements, further cementing its position as a leading modality in radiation oncology. The integration of image-guided radiation therapy (IGRT) with IMRT has significantly improved the accuracy of treatment delivery by incorporating real-time imaging to account for tumor movement and patient positioning. This combination ensures that radiation is delivered precisely to the intended target, even in dynamic anatomical regions such as the lungs and abdomen. Additionally, advancements in treatment planning software and machine learning algorithms are enabling more personalized and adaptive radiation therapy. These innovations allow clinicians to tailor treatments based on individual patient characteristics, tumor biology, and response to therapy. The adoption of automated treatment planning systems is also reducing the time required to develop complex IMRT protocols, enhancing operational efficiency in oncology centers. Furthermore, emerging technologies such as proton therapy are being integrated with IMRT to provide even greater precision, opening new frontiers in the treatment of pediatric and hard-to-treat cancers.

What Are the Key Market Trends in the Adoption of IMRT?

The adoption of IMRT is growing rapidly across diverse healthcare settings, from large oncology centers to smaller community hospitals. In developed regions such as North America and Europe, well-established healthcare infrastructures and favorable reimbursement policies have facilitated the widespread implementation of IMRT. These regions are also witnessing a surge in demand for advanced radiation therapy technologies due to the increasing prevalence of lifestyle-related cancers and aging populations. Emerging markets, particularly in Asia-Pacific, are experiencing a significant uptick in IMRT adoption due to rising healthcare investments and growing awareness of advanced cancer treatment options. Governments in countries like China and India are prioritizing the establishment of specialized cancer treatment centers equipped with state-of-the-art technologies like IMRT to address the region’s burgeoning cancer burden. Moreover, private healthcare providers are increasingly partnering with technology vendors to offer cutting-edge IMRT solutions, enhancing the quality of oncology care in these regions.

What Factors Are Driving the Growth of the IMRT Market?

The growth in the Intensity Modulated Radiation Therapy market is driven by several factors, including the increasing global burden of cancer, the rising demand for precision medicine, and advancements in radiation therapy technologies. The growing awareness of the benefits of IMRT in reducing treatment-related complications and improving survival rates is a key driver of market growth. Additionally, supportive government policies and funding initiatives aimed at improving access to advanced cancer treatments are playing a significant role in the market’s expansion. End-use trends are also shaping the market, with hospitals, cancer treatment centers, and specialized radiation oncology clinics being the primary adopters of IMRT. The growing preference for outpatient cancer care has further boosted demand for compact and cost-effective IMRT systems. Meanwhile, advancements in telemedicine and remote treatment planning are enabling wider access to IMRT in underserved areas, addressing geographical disparities in cancer care. Collectively, these factors underscore the strategic importance of IMRT in revolutionizing cancer treatment and meeting the evolving needs of patients and healthcare providers worldwide.

SCOPE OF STUDY:

The report analyzes the Intensity Modulated Radiation Therapy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Radiation Type (Electron Radiation, Carbon-Ion Radiation, Photon Radiation, Proton Radiation); Application (Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application, Brain Cancer Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 52 Featured) -

  • Accuray, Inc.
  • Brainlab AG
  • Elekta AB
  • IBA Dosimetry GmbH
  • Mevion Medical Systems, Inc.
  • Panacea Medical Technologies Pvt. Ltd.
  • Protom International
  • RAYSEARCH Laboratories AB
  • Reflexion Medical, Inc.
  • Siemens Healthineers AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Economic Frontiers: Trends, Trials & Transformations
    • Intensity Modulated Radiation Therapy - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cancer Fuels Demand for Intensity Modulated Radiation Therapy (IMRT)
    • Advancements in Imaging Technologies Propel Innovation in IMRT Techniques
    • Focus on Precision and Reduced Side Effects Drives Adoption of IMRT
    • Integration with AI and Machine Learning Enhances Treatment Planning in IMRT
    • Increasing Use of IMRT in Pediatric Oncology Expands Applications
    • Focus on Real-Time Tumor Monitoring Strengthens Demand for Adaptive IMRT Solutions
    • Rising Awareness of Patient-Centric Care Drives Growth in Personalized IMRT Treatments
    • Advancements in Linear Accelerator Technologies Boost Efficiency of IMRT Systems
    • Growth in Radiation Therapy Centers Expands Accessibility to IMRT Treatments
    • Focus on Cost-Effective Treatment Options Drives Development of Scalable IMRT Solutions
    • Integration with Proton Therapy Systems Creates New Opportunities for IMRT
    • Rising Adoption of Cloud-Based Platforms Enhances Data-Driven IMRT Planning
    • Emergence of AI-Driven Quality Assurance Systems Improves Accuracy in IMRT Delivery
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Intensity Modulated Radiation Therapy Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Intensity Modulated Radiation Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Electron Radiation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Electron Radiation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Carbon-Ion Radiation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Carbon-Ion Radiation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Photon Radiation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Photon Radiation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Proton Radiation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Proton Radiation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Breast Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Breast Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Prostate Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Prostate Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Gynecological Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Gynecological Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Lung Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Lung Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Brain Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Brain Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 24: USA Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • CANADA
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • JAPAN
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • CHINA
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 36: China Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: China 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • EUROPE
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 41: Europe 6-Year Perspective for Intensity Modulated Radiation Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Europe 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • FRANCE
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 46: France Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: France 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 48: France Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: France 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • GERMANY
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 50: Germany Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Germany 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 52: Germany Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Germany 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • ITALY
    • TABLE 54: Italy Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Italy 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 56: Italy Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Italy 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • UNITED KINGDOM
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 58: UK Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: UK 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 60: UK Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: UK 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 62: Rest of Europe Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Rest of Europe 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 64: Rest of Europe Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Rest of Europe 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 66: Asia-Pacific Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Asia-Pacific 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 68: Asia-Pacific Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Asia-Pacific 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 70: Rest of World Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Rest of World 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 72: Rest of World Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Rest of World 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030

IV. COMPETITION